Drreddys Laboratories reported 42.59B in Operating Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Ani Pharmaceuticals ANIP:US $ 64.18M 12.7M
Aphria Inc APH:CN C$ 221.95M 18.21M
Bayer BAYN:GR 13.14B 3.89B
Canopy Growth Corp WEED:CN C$ 326.26M 54.75M
Catalent CTLT:US $ 937.7M 235.8M
Cipla CIPLA:IN 45.44B 4.49B
Corcept Therapeutics CORT:US $ 59.64M 154K
Drreddys Laboratories RDY:US 42.59B 966M
Endo International Ordinary Shares ENDP:US $ 570.72M 35.49M
GlaxoSmithKline GSK:LN 6.42B 692M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Hikma Pharmaceutical HIK:LN 873M 27M
Horizon Pharma HZNP:US $ 694.03M 191.61M
JAZZ PHA JAZZ:US $ 821.4M 375.94M
Lannett LCI:US $ 139.83M 30.31M
Lonza Group LONN:SW 2.22B 1.07B
Novartis NOVN:VX 9.82B 464M
Pacira Pharmaceuticals PCRX:US $ 100.75M 1.16M
Phibro Animal Health PAHC:US $ 201.12M 9.52M
Prestige Brands PBH:US $ 177.84M 1.31M
Richter Gedeon RICHT:HB 119.49B 2.98B
Sun Pharmaceuticals SUNP:IN IR 81118.3M 4217.7M
Supernus Pharmaceuticals SUPN:US $ 107.22M 10.5M
Teva Pharmaceutical TEVA:IT 3.33B 220M